Dr. Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India
HYDERABAD: Dr. Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India. This will be a multi-center and randomized controlled study, which will include safety and immunogenicity study. Earlier in September…